BioStock: Enzymatica comments on MDR certification for ColdZyme

Enzymatica has received CE certification for ColdZyme under the EU’s new Medical Device Regulation. According to the company, this is an important milestone that validates their scientific and regulatory foundation. Additionally, the certification provides an opportunity to expand both the intended use and product claims for ColdZyme. BioStock interviewed Ann-Christine Provoost, Director Regulatory Affairs, to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/03/enzymatica-comments-on-mdr-certification-for-coldzyme/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se